Sunpla expected yearly to yeild 10 billion won of sales

Published: 1999-07-20 11:24:00

Updated: 1999-07-20 11:24:00

As reported earlier SK Chemical and SK Pharmaceutical has developed an anti-cancer drug, a platinum complex, under the brand of Sunpla by about 8.1 billion won of investment during the past 10 years, which becomes the first drug having a new chemical entity in history of Korea. The followings are...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK